Inflammation in osteoarthritis.

Imagen de Miguel Otero
PDF versionPDF version
TítuloInflammation in osteoarthritis.
Publication TypeJournal Article
Year of Publication2011
AutoresGoldring, MB, Otero, M
JournalCurr Opin Rheumatol
Volume23
Issue5
Pagination471-8
Date Published2011 Sep
ISSN1531-6963
Palabras claveAging, Animals, Biomechanical Phenomena, Cytokines, Epigenesis, Genetic, Extracellular Matrix, Humans, Inflammation, Inflammation Mediators, MicroRNAs, Obesity, Osteoarthritis, Signal Transduction, Stress, Mechanical, Synovitis
Abstract

PURPOSE OF REVIEW: This review focuses on the novel stress-induced and proinflammatory mechanisms underlying the pathogenesis of osteoarthritis, with particular attention to the role of synovitis and the contributions of other joint tissues to cellular events that lead to the onset and progression of the disease and irreversible cartilage damage.

RECENT FINDINGS: Studies during the past 2 years have uncovered novel pathways that, when activated, cause the normally quiescent articular chondrocytes to become activated and undergo a phenotypic shift, leading to the disruption of homeostasis and ultimately to the aberrant expression of proinflammatory and catabolic genes. Studies in animal models and retrieved human tissues indicate that proinflammatory factors may be produced by the chondrocytes themselves or by the synovium and other surrounding tissues, even in the absence of overt inflammation, and that multiple pathways converge on the upregulation of aggrecanases and collagenases, especially MMP-13. Particular attention has been paid to the contribution of synovitis in posttraumatic joint injury, such as meniscal tears, and the protective role of the pericellular matrix in mediating chondrocyte responses through receptors, such as discoidin domain receptor-2 and syndecan-4. New findings about intracellular signals, including the transcription factors NF-κB, C/EBPβ, ETS, Runx2, and hypoxia-inducible factor-2α, and their modulation by inflammatory cytokines, chemokines, adipokines, Toll-like receptor ligands, and receptor for advanced glycation end-products, as well as CpG methylation and microRNAs, are reviewed.

SUMMARY: Further work on mediators and pathways that are common across different models and occur in human osteoarthritis and that impact the osteoarthritis disease process at different stages of initiation and progression will inform us about new directions for targeted therapies.

DOI10.1097/BOR.0b013e328349c2b1
Alternate JournalCurr Opin Rheumatol
PubMed ID21788902
PubMed Central IDPMC3937875
Grant ListR01 AG022021 / AG / NIA NIH HHS / United States
R01 AG022021-09 / AG / NIA NIH HHS / United States
R01-AG022021 / AG / NIA NIH HHS / United States
R21 AR054887 / AR / NIAMS NIH HHS / United States
R21 AR054887-02 / AR / NIAMS NIH HHS / United States
R21-AR054887 / AR / NIAMS NIH HHS / United States
RC4 AR060546 / AR / NIAMS NIH HHS / United States
RC4 AR060546 / AR / NIAMS NIH HHS / United States
RC4 AR060546-01 / AR / NIAMS NIH HHS / United States